Fatty acids don't reduce atrial fibrillation recurrence

Fatty acids don't reduce atrial fibrillation recurrence
Polyunsaturated fatty acids do not reduce the recurrence of atrial fibrillation, according to a study published online Dec. 19 in the Journal of the American College of Cardiology.

(HealthDay)—Polyunsaturated fatty acids (n-3 PUFA) do not reduce the recurrence of atrial fibrillation (AF), according to a study published online Dec. 19 in the Journal of the American College of Cardiology.

Alejandro Macchia, M.D., from Grupo de Estudio de Investigacion Clinica en Argentina in Buenos Aires, and colleagues randomly assigned outpatients with confirmed symptomatic paroxysmal AF that required cardioversion (428 patients), at least two episodes of AF in the six months before randomization (55), or both (103), to receive n-3 PUFA (1 g/day) or placebo for 12 months.

The researchers found that, for symptomatic recurrence of AF, there was no significant difference between the two groups, with 56 of 297 participants (18.9 percent) in the and 69 of 289 participants (24.0 percent) in the n-3 PUFA group having recurrent symptomatic AF (hazard ratio, 1.28; P = 0.17). There was also no difference between the two groups for the composite of all-cause mortality, nonfatal stroke, nonfatal , systemic embolism, heart failure development, or severe bleeding. The composite end point occurred in 20 patients (6.7 percent) and 16 patients (5.5 percent) randomized to placebo or n-3 PUFA, respectively (hazard ratio, 0.86; P = 0.65).

"Pharmacological supplementation with 1 g of n-3 PUFA for one year did not reduce recurrent AF," the authors write.

The study was funded by the Società Prodotti Antibiotici and Sigma Tau Pharmaceuticals, both of which provided the study drugs.

More information: Abstract
Full Text

Related Stories

The Medical Minute: Atrial Fibrillation -- What is It?

date Oct 06, 2011

Atrial fibrillation (AF) is the most common heart rhythm disturbance in the United States and affects 2 to 4 million Americans. It is usually a disease of aging, however it can affect people of all ages -- 1 percent of people ...

Recommended for you

Cognitive impairment predicts worse outcome in heart failure

date 11 hours ago

Cognitive impairment predicts worse outcome in elderly heart failure patients, reveals research presented today at Heart Failure 2015 by Hiroshi Saito, a physiotherapist at Kameda Medical Centre in Kamogawa, Japan. Patients ...

1950s drug is future heart treatment

date May 22, 2015

Oxford University researchers have found a promising future treatment for heart disease, going back to a drug first developed in 1950.

Time is muscle in acute heart failure

date May 21, 2015

Urgent diagnosis and treatment in acute heart failure has been emphasised for the first time in joint recommendations published today in European Heart Journal.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.